Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://dx.doi.org/10.25673/117375
Titel: Image-guided Embolotherapy of Arteriovenous malformations of the face
Autor(en): Schmidt, Vanessa FranziskaIn der Gemeinsamen Normdatei der DNB nachschlagen
Masthoff, MaxIn der Gemeinsamen Normdatei der DNB nachschlagen
Brill, RichardIn der Gemeinsamen Normdatei der DNB nachschlagen
Sporns, Peter B.In der Gemeinsamen Normdatei der DNB nachschlagen
Köhler, Michael
Schulze-Zachau, VictorIn der Gemeinsamen Normdatei der DNB nachschlagen
Takes, Martin
Ehrl, DenisIn der Gemeinsamen Normdatei der DNB nachschlagen
Puhr-Westerheide, DanielIn der Gemeinsamen Normdatei der DNB nachschlagen
Kunz, Wolfgang GerhardIn der Gemeinsamen Normdatei der DNB nachschlagen
Shemwetta, Mwivano Dunstan
Mbuguje, Eric M.
Naif, Azza A.
Sarkar, Abizer Sarkar
Ricke, JensIn der Gemeinsamen Normdatei der DNB nachschlagen
Seidensticker, MaxIn der Gemeinsamen Normdatei der DNB nachschlagen
Wohlgemuth, Walter A.In der Gemeinsamen Normdatei der DNB nachschlagen
Wildgruber, MoritzIn der Gemeinsamen Normdatei der DNB nachschlagen
Erscheinungsdatum: 2022
Art: Artikel
Sprache: Englisch
Zusammenfassung: Purpose: To evaluate the safety and outcome of image-guided embolotherapy of extracranial arteriovenous malformations (AVMs) primarily affecting the face. Materials and Methods: A multicenter cohort of 28 patients presenting with AVMs primarily affecting the face was retrospectively investigated. Fifty image-guided embolotherapies were performed, mostly using ethylene–vinyl alcohol copolymer-based embolic agents. Clinical and imaging findings were assessed to evaluate response during follow-up (symptom-free, partial relief of symptoms, no improvement, and progression despite embolization), lesion devascularization (total, 100%; substantial, 76–99%; partial, 51–75%; failure, < 50%; and progression), and complication rates (classified according to the CIRSE guidelines). Sub-analyses regarding clinical outcome (n = 24) were performed comparing patients with (n = 12) or without (n = 12) subsequent surgical resection after embolotherapy. Results: The median number of embolotherapy sessions was 2.0 (range, 1–4). Clinical outcome after a mean follow-up of 12.4 months (± 13.3; n = 24) revealed a therapy response in 21/24 patients (87.5%). Imaging showed total devascularization in 14/24 patients (58.3%), including the 12 patients with subsequent surgery and 2 additional patients with embolotherapy only. Substantial devascularization (76–99%) was assessed in 7/24 patients (29.2%), and partial devascularization (51–75%) in 3/24 patients (12.5%). Complications occurred during/after 12/50 procedures (24.0%), including 18.0% major complications. Patients with subsequent surgical resections were more often symptom-free at the last follow-up compared to the group having undergone embolotherapy only (p = 0.006). Conclusion: Image-guided embolotherapy is safe and effective for treating extracranial AVMs of the face. Subsequent surgical resections after embolization may substantially improve patients’ clinical outcome, emphasizing the need for multimodal therapeutic concepts.
URI: https://opendata.uni-halle.de//handle/1981185920/119334
http://dx.doi.org/10.25673/117375
Open-Access: Open-Access-Publikation
Nutzungslizenz: (CC BY 4.0) Creative Commons Namensnennung 4.0 International(CC BY 4.0) Creative Commons Namensnennung 4.0 International
Journal Titel: CardioVascular and interventional radiology
Verlag: Springer
Verlagsort: Berlin
Band: 45
Originalveröffentlichung: 10.1007/s00270-022-03169-0
Seitenanfang: 992
Seitenende: 1000
Enthalten in den Sammlungen:Open Access Publikationen der MLU

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
s00270-022-03169-0.pdf491.65 kBAdobe PDFMiniaturbild
Öffnen/Anzeigen